Rare disease market research needs a multifaceted approach
Published on 27 Nov 2017
By Caroline Mathie
discusses some of the challenges in researching rare diseases, what the broader
market can learn from observing these approaches, and the role of online
research in particular.
Earlier this year, England’s chief medical officer called for the ‘genomic dream’ of genome sequencing for all cancer and rare disease patients. Accelerated use of genome sequencing is allowing the identification of ever rarer diseases – a recent case in point being six children who were identified through an international database of genes and disease characteristics as having the same ASXL2 gene mutation. This answers two fundamental needs experienced by those with rare diseases; (1) knowing the cause of their problem and (2) the ability to share their experiences with others with the same condition. It also presents the industry with an opportunity to address the root cause of the disease through targeted therapies.
By March 2017, 49.7% of the world’s population had access to
the internet (88% in North America and 77% in Europe) – figures that are
growing rapidly. Unsurprisingly, this access is a valuable tool for researching
rare diseases. In Germany alone, the Journal of Medical Internet Research
(January 2017) identified 693 websites containing information on rare diseases,
many of them provided by support groups/patient organisations and showed that
these are extremely valuable sources of information for patients and their families.
A high proportion of internet users engage with social
media, including Facebook and Twitter, and there are many social media support
groups for a wide range of rare and ultra-rare medical conditions. As
genome-wide analyses, such as exome or wholegenome sequencing, become more
commonplace, it is likely that the number of patient groups for rare diseases
on social media will increase substantially.
Problem and opportunity
Having a rare disease can feel lonely, and rare disease patients
are already fighting their isolation through social media, and by linking to
others with the same condition. However, internet access also offers new
opportunities in terms of specialist consultation, and patient education.
As new diseases are identified, ever more patients are
forced to travel long distances for lengthy periods of time to specialised
treatment centres. Each new disease may require a multi-disciplinary team,
sparking the need for information and education for patients, carers and often
other treating healthcare professionals (HCPs).
The use of the internet, to share information and for discussion, has become critical to both reduce the burden on health services and give patients the information they want at the time they want or need it. Forward-looking specialists are now looking at technological advances to enable at least some consultations with patients via video conferencing. However, though they may relieve logistical and time burdens for patients, fears have been expressed that they may be clinically risky and associated with significant technical, logistical and regulatory challenges.
Opportunity and challenge
Patient forums are having a dramatic effect on the world of
market research. They often emerge spontaneously after a small number of
patients set up networks or communities to address their needs for information
and to share experiences. These types of forums – and other, more established,
groups – have been great tools for market researchers to gather information
about the experiences of people with rare diseases, as they allow thorough
observations of forum conversations. However, the forums may become hidden, as
closed or invitation-only groups, if they become unwelcome targets for pharma
and the healthcare industry. Thus, what could have been an opportunity for
market researchers can turn into a frustrating difficulty.
Another problem with forums is that the industry itself has
ethical and compliance concerns regarding too much contact with individual
Nevertheless, the emergence and growth of patient forums suggest that the fabric of the rare disease market research world may have to change from ad hoc recruitment for interviews to a multiprong approach which includes much longer-term community observation.
All is not lost, however. When it comes to using online
forums and communities for rare disease market research, we can, for example,
set up our own ongoing network or community. To be effective, this requires
knowledgeable and effective moderation – continuously – which is costly.
However, it does provide the ability to address recruitment
issues with a specific set of patients and, more importantly, facilitates an
understanding of the longitudinal journeys of different patients and their
families through listening to their views over time. The community also
provides the ability to identify common points on the patient journey and the
needs they have and the questions they are asking at each, to build a
comprehensive picture of homogenous vs diverse or segmented needs.
Less costly, but effective, is to ask to join the specific
closed communities as market researchers. Some forums allow this and some do
Patients can also be researched using standard approaches
online, which, of course, come with the usual online issues. With rare
diseases, questions around patient identification are more significant, as is
making absolutely sure the patient really is a patient. Guaranteed security and
compliance must also be in place. Finally, if clients are given access to
listen to communities, specific patient identifiers need to be removed, and if
it is a short-term moderated community, any inputs or questions should not
reveal the identity of patients.
Market research – a
change in approach
As part of the market research industry we need to explore
both a change in approach and, potentially, a change in the business
relationship we have with our clients if rare disease market research is to be
We also need to discuss our approach to dealing with
duty-of-care issues up front, if we establish a long-term, moderated community.
Clearly there is also a role for traditional research
approaches for these isolated patients using the web, such as teleweb
interviews and Skype. Visual connection is also helpful to create rapport and
reduce the sense of isolation.
The market research model for rare diseases is changing and to benefit from the richness of data produced by long-term patient communities, we need to think differently, set up relationships differently and consider not only the market research, security and compliance aspects, but also the ethical duty-of-care issues to sustain communities that may become important components of patients’ lives, especially genuine patients’ perspectives. Targeted utilisation of such insights can bring significant competitive advantage. Therefore, pharma companies should embrace social media listening to help them implement further actions appropriately for greater commercial success.
About the author
Caroline leads the Rare Disease Group at THE PLANNING SHOP.
After studying Medical Biochemistry, she spent 14 years at IMS Health, over 10
years as an independent, director level consultant and four years as a director
at J & D Associates. Throughout her career, Caroline has had an active
interest in orphan diseases and has expertise in a wide range of orphan disease
conditions, including various lysosomal storage disorders.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
We’d like to set analytic software i.e. Google Analytics/Click Dimensions to help us improve our website by collecting and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone. For more information on how these cookies work, please see our Cookies Policy.